CSVAX | TRIGX | CSVAX / TRIGX | |
Total Expense Ratio | 1.20 | 0.87 | 138% |
Annual Report Gross Expense Ratio | 1.30 | 0.87 | 149% |
Fund Existence | 23 years | 27 years | - |
Gain YTD | 19.176 | 31.371 | 61% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 574M | 16.1B | 4% |
Annual Yield % from dividends | 2.05 | 1.96 | 105% |
Returns for 1 year | 8.64 | 24.64 | 35% |
Returns for 3 years | 47.59 | 89.02 | 53% |
Returns for 5 years | 37.43 | 100.33 | 37% |
Returns for 10 years | 54.36 | 97.06 | 56% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 23.00 | 0.43 | +1.91% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
HELX | 30.62 | 0.36 | +1.20% |
Franklin Genomic Advancements ETF | |||
CBOA | 26.59 | 0.05 | +0.19% |
Calamos Bitcoin Structured Alt Protection ETF - April | |||
IBDU | 23.49 | 0.04 | +0.17% |
iShares iBonds Dec 2029 Term Corp ETF | |||
SIXA | 49.59 | -0.17 | -0.35% |
ETC 6 Meridian Mega Cap Equity ETF |